Crossmark

Individualized gamma knife radiosurgery prescription dosing for pituitary adenomas: development and internal validation of a feedforward neural network model

Crossref DOI link: https://doi.org/10.1007/s11102-026-01645-1

Published Online: 2026-02-09

Published Print: 2026-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Reyes, Jheremy S.

Dhol, Vidhan K.

Bouras, Alexandros

Zenonos, Georgios

Lunsford, L. Dade

Niranjan, Ajay

Hadjipanayis, Constantinos G.
License Information

Text and Data Mining valid from 2026-02-01

Version of Record valid from 2026-02-01
More Information

Article History

Received: 17 December 2025

Accepted: 27 January 2026

First Online: 9 February 2026

Declarations

:

: This study was conducted under an IRB protocol (STUDY20010256). All methods conformed to the Declaration of Helsinki and institutional standards regarding patient privacy and safety.

: Obtained.

: Not applicable.

: Constantinos Hadjipanayis is a paid consultant for Stryker Corp., Synaptive Medical, and Hemerion Therapeutics. All other authors have no disclosures and declare no competing interests with respect to this work.

Document is current

Any future updates will be listed below